
Pamela J. Schlembach MD
Breast Cancer, Central Nervous System Cancer
Professor Radiation Oncology and Center Medical Director MD Anderson Woodlands
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Schlembach is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pamela Schlembach is a Radiation Oncologist based in Houston, TX, specializing in breast and central nervous system cancers. Educated at The University of Toledo College of Medicine, she completed her residency at the University of Texas MD Anderson Cancer Center where she joined the faculty. She has been serving as a professor in Radiation Oncology at MD Anderson Cancer Center since 2002 and has significant clinical and research experience. Dr. Schlembach is the center medical director of The MD Anderson Woodlands campus and has authored multiple publications, contributing to journals including the Journal of Clinical Oncology, with her work being cited several times. Her honors include awards for excellence in service and community outreach, and she has been recognized among Houston's influential women and nominated by her peers at MD Anderson in Radiation Oncology for her outstanding service.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1998 - 2002
The University of Toledo College of MedicineClass of 1997
University of ToledoBS, Institutional Healthcare Management, 1992
Owens Technical CollegeAD, Radiological Technology, 1977
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
GA State Medical License 2023 - 2028
TN State Medical License 2023 - 2028
LA State Medical License 2023 - 2027
OK State Medical License 2020 - 2027
AL State Medical License 2023 - 2026
American Board of Radiology Radiation Oncology- Join now to see all
Awards, Honors, & Recognition
- Excellence in Service - Internal and Extramural Award in Radiation Oncology University of Texas MD Anderson Cancer Center, 2024
- Community Outreach Excellence Award MD Anderson Faculty Excellence Award, 2023
- Trailblazer Award 2022 Greater Houston Women's Summit, 2022
Publications & Presentations
PubMed
- Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial.Grace L Smith, Chi-Fang Wu, Melissa Joyner, Pamela J Schlembach, Elizabeth S Bloom
International Journal of Radiation Oncology, Biology, Physics. 2026-06-15 - 3 citationsHypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Ra...Comron Hassanzadeh, Deborah Kuban, Sarah Pasyar, Roland Bassett, Patricia Troncoso
Journal of Clinical Oncology. 2025-06-20 - 6 citationsOutcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer.Luisa E Jacomina, David M Swanson, Melissa P Mitchell, Wendy A Woodward, Benjamin D Smith
International Journal of Radiation Oncology, Biology, Physics. 2025-06-01
Journal Articles
- Locoregional Management and Prognostic Factors in Breast Cancer Patients with Ipsilateral Internal Mammary and Axillary Lymph Node InvolvmentAndring L, Woodward W, Schlembach, P, Smith B, International Journal of Radiation Oncology Biology Physics, 3/2022
- Association of Transforming Growth Factor Β Polymorphism C−509T with Radiation-Induced Fibrosis Among Patients with Early-Stage Breast CancerA Secondary Analysis of a ...Karen E Hoffman, Elizabeth S Bloom, Pamela J Schlembach, Thomas A Buchholz, Benjamin D Smith, Wendy A Woodward, Welela Tereffe, Simona F Shaitelman, Michael C Stauder, JAMA
- 19. M Consideration of Patient Characteristics and Comorbidity in Selecting Candidates for Moderately Hypofractionated Radiation: Secondary analysis from a randomized ...oningi S, Kuban D, Allen P, Choi S, Frank S, Nguyen Q, McGuire S, Skinner H, Schlembach P, Voong R, Hoffman K., Int J Radiat Oncol Biol Phys 99(2):S155-S156, 10/2017., 10/2017
Abstracts/Posters
- Optimizing Houston Area Locations Ambulatory Radiation Oncology Consult Workflow Using Patient Flow Analysis with Real-Time Patient TrackingWeng J, Chronowski G, Smith R, Ehlers R, Schlembach P, Mayo L, Joyner, M, Shah S, Arzu I, Nguyen Q, American Radium Society, Scottsdale AZ, 5/19/2022
- General Poster Session A: Science of Quality.Ballo, Matthew; Chronowski, Gregory;Schlembach, Pamela;Bloom, Elizabeth;Arzu, Isadora;Kuban, Deborah, J Clin Oncol, 1/1/2013
- Comparison of Intensity Modulated Radiotherapy Versus Conventional Treatment Planning in Bilateral and Unilateral Post-Operative Thyroid CancerSchlembach, Pamela J, American Radium Society, Houston, TX, 1/1/2003
Lectures
- Breast Cancer UpdatesInstanbul, Turkey - 1/1/2015
- Breast Cancer-Early stage: hypofractionation and APBIAdana, Turkey - 1/1/2015
- Cardiac sparing.Adana, Turkey - 1/1/2015
Other
- How to cope with Insomnia during cancer treatment.Schlembach, Pamela J, Cancerwise
1/10/2015 - Breast Cancer Treatment and Risk FactorsSchlembach, Pamela J, The Victor Trevino Show
Houston, TX - 1/21/2014 - "8 Tips for Coping with Cancer-Related Lymphedema."Schlembach, Pamela J, Cancerwise
http://www2.mdanderson.org/cancerwise/2014/03/6-tips-for-coping-with-cancer-related-lymphedema.html
1/20/2014
Press Mentions
Triple-Negative Breast Cancer Survivor: MD Anderson Is ‘A Hospital like No Other’January 24th, 2023
Valentine’s Day Event at MD Anderson the Woodlands Spreads Love to Breast Cancer Patients and SurvivorsFebruary 14th, 2020
Best of Cancerwise 2018: Helpful Insights from Our ExpertsDecember 19th, 2018
Committees
- Co chair, Breast Multidisciplinary Team 2010 - Present
- Co-chair, Bootwalk to end cancer MDA Anderson Cancer Center 2021 - 2023
- Senator, Faculty senate 2021 - 2023
- Champion, Service Excellence MD Anderson 2018 - 2021
- Co-chair, Frontiers of Interdisciplinary Personalized Cancer Therapy, MDAPN, Conference 2011 - 2012
Research History
- Collaborator, Impact of the Oncotype DX DCIS Score on Treatment Decision Making in Patients with Ductal Carcinoma in Situ, 2013-0849Genomic Health2014 - 2017
- Collaborator, A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III NSCLC, RTOG1306Astellas Pharma and Pfizer2014 - 2017
- CollaboratorStandard fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.2011 - 2017
- CollaboratorXRT for rising PSA post prostatectomy, 2008-02542011 - 2017
- Collaborator, 2nd authorConventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.2010 - 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:













